Nucleic Acids Research, 2001, Vol. 29, No. 12 2502-2509
© 2001 Oxford University Press
An unusually compact external promoter for RNA polymerase III transcription of the human H1RNA gene
UPR 9002 du CNRS ‘Structure des Macromolécules Biologiques et Mécanismes de Reconnaissance’, Institut de Biologie Moléculaire et Cellulaire, 15 rue René Descartes, 67084 Strasbourg Cedex, France and 1UPR 9003 du CNRS, Ecole Supérieure de Biotechnologie de Strasbourg, Boulevard Sébastien Brant, 67400 Illkirch, France
H1 RNA, the RNA component of the human nuclear RNase P, is encoded by a unique gene transcribed by RNA polymerase III (Pol III). In this work, cis-acting elements and trans-acting factors involved in human H1 gene transcription were characterized by transcription assays of mutant templates and DNA binding assays of recombinant proteins. Four elements, lying within 100 bp of 5'-flanking sequences, were defined to be essential for maximal in vitro and in vivo expression, consisting of the octamer, Staf, proximal sequence element (PSE) and TATA motifs. These are also encountered in the promoter elements of vertebrate snRNA genes, where the first two constitute the distal sequence element (DSE). In all the genes examined so far, the DSE is distant from the PSE and TATA box that compose the basal promoter. However, we observed a fundamental difference in the organization of the H1 RNA and snRNA gene promoters with respect to the relative spacing of the DSE and PSE. Indeed, the H1 promoter is unusually compact, with the octamer motif and Staf binding site adjacent to the PSE and TATA motifs. It thus appears that the human RNase P RNA gene has adopted a unique promoter strategy placing the DSE immediately adjacent to the basal promoter.
* To whom correspondence should be addressed. Tel: +33 3 88 41 70 64; Fax: +33 3 88 60 22 18; Email: p.carbon{at}ibmc.u-strasbg.fr
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. A. Ponguta, C. W. Gregory, F. S. French, and E. M. Wilson Site-specific Androgen Receptor Serine Phosphorylation Linked to Epidermal Growth Factor-dependent Growth of Castration-recurrent Prostate Cancer J. Biol. Chem., July 25, 2008; 283(30): 20989 - 21001. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Henriksen, C. Lokke, M. Hammero, D. Geerts, R. Versteeg, T. Flaegstad, and C. Einvik Comparison of RNAi efficiency mediated by tetracycline-responsive H1 and U6 promoter variants in mammalian cell lines Nucleic Acids Res., May 14, 2007; 35(9): e67 - e67. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Myslinski, M.-A. Gerard, A. Krol, and P. Carbon Transcription of the human cell cycle regulated BUB1B gene requires hStaf/ZNF143 Nucleic Acids Res., May 11, 2007; 35(10): 3453 - 3464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Brenz Verca, P. Weber, C. Mayer, C. Graf, D. Refojo, R. Kuhn, I. Grummt, and B. Lutz Development of a species-specific RNA polymerase I-based shRNA expression vector Nucleic Acids Res., January 28, 2007; 35(2): e10 - e10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Myslinski, M.-A. Gerard, A. Krol, and P. Carbon A Genome Scale Location Analysis of Human Staf/ZNF143-binding Sites Suggests a Widespread Role for Human Staf/ZNF143 in Mammalian Promoters J. Biol. Chem., December 29, 2006; 281(52): 39953 - 39962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kappel, Y. Matthess, B. Zimmer, M. Kaufmann, and K. Strebhardt Tumor inhibition by genomically integrated inducible RNAi-cassettes Nucleic Acids Res., September 11, 2006; 34(16): 4527 - 4536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Mi, X. Zhang, Z. N Rabbani, Y. Liu, Z. Su, Z. Vujaskovic, C. D. Kontos, B. A. Sullenger, and B. M. Clary H1 RNA polymerase III promoter-driven expression of an RNA aptamer leads to high-level inhibition of intracellular protein activity Nucleic Acids Res., July 19, 2006; 34(12): 3577 - 3584. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gray, A. M. Jubb, D. Hogue, P. Dowd, N. Kljavin, S. Yi, W. Bai, G. Frantz, Z. Zhang, H. Koeppen, et al. Maternal Embryonic Leucine Zipper Kinase/Murine Protein Serine-Threonine Kinase 38 Is a Promising Therapeutic Target for Multiple Cancers Cancer Res., November 1, 2005; 65(21): 9751 - 9761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Chen, L. Zhang, H.-Y. Zhang, X. Xiong, B. Wang, Q. Du, B. Lu, C. Wahlestedt, and Z. Liang A universal plasmid library encoding all permutations of small interfering RNA PNAS, February 15, 2005; 102(7): 2356 - 2361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bardeleben, R. L. Moore, and R. K. Wayne Isolation and Molecular Evolution of the Selenocysteine tRNA (Cf TRSP) and RNase P RNA (Cf RPPH1) Genes in the Dog Family, Canidae Mol. Biol. Evol., February 1, 2005; 22(2): 347 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Dave and R. J. Pomerantz Antiviral Effects of Human Immunodeficiency Virus Type 1-Specific Small Interfering RNAs against Targets Conserved in Select Neurotropic Viral Strains J. Virol., December 15, 2004; 78(24): 13687 - 13696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Futaki, Y. Hayashi, T. Emoto, C. N. Weber, and K. Sekiguchi Sox7 Plays Crucial Roles in Parietal Endoderm Differentiation in F9 Embryonal Carcinoma Cells through Regulating Gata-4 and Gata-6 Expression Mol. Cell. Biol., December 1, 2004; 24(23): 10492 - 10503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Strack, J. T. Cribbs, and L. Gomez Critical Role for Protein Phosphatase 2A Heterotrimers in Mammalian Cell Survival J. Biol. Chem., November 12, 2004; 279(46): 47732 - 47739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-E. Mangeot, F.-L. Cosset, P. Colas, and I. Mikaelian A universal transgene silencing method based on RNA interference Nucleic Acids Res., July 12, 2004; 32(12): e102 - e102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sivakumaran, S.-K. Choi, M. Hema, and C. C. Kao Requirements for Brome Mosaic Virus Subgenomic RNA Synthesis In Vivo and Replicase-Core Promoter Interactions In Vitro J. Virol., June 15, 2004; 78(12): 6091 - 6101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Lu, L. G. Burdelya, S. M. Swiatkowski, A. D. Boiko, P. H. Howe, G. R. Stark, and A. V. Gudkov Secreted transforming growth factor {beta}2 activates NF-{kappa}B, blocks apoptosis, and is essential for the survival of some tumor cells PNAS, May 4, 2004; 101(18): 7112 - 7117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-I. Hwang, I. D. C. Fraser, S. Choi, X.-F. Qin, and M. I. Simon From the Cover: Analysis of C5a-mediated chemotaxis by lentiviral delivery of small interfering RNA PNAS, January 13, 2004; 101(2): 488 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-T. M. Lee, G. A. Coburn, M. O. McClure, and B. R. Cullen Inhibition of Human Immunodeficiency Virus Type 1 Replication in Primary Macrophages by Using Tat- or CCR5-Specific Small Interfering RNAs Expressed from a Lentivirus Vector J. Virol., November 15, 2003; 77(22): 11964 - 11972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Boden, O. Pusch, F. Lee, L. Tucker, P. R. Shank, and B. Ramratnam Promoter choice affects the potency of HIV-1 specific RNA interference Nucleic Acids Res., September 1, 2003; 31(17): 5033 - 5038. [Abstract] [Full Text] [PDF]
|
|